The impact of low-frequency, low-force cyclic stretching of human bronchi on airway responsiveness by Morgan Le Guen et al.
RESEARCH Open Access
The impact of low-frequency, low-force
cyclic stretching of human bronchi on
airway responsiveness
Morgan Le Guen1,2*, Stanislas Grassin-Delyle1, Emmanuel Naline1, Amparo Buenestado1, Marion Brollo1,
Elisabeth Longchampt3, Philippe Kleinmann4, Philippe Devillier1 and Christophe Faisy1
Abstract
Background: In vivo, the airways are constantly subjected to oscillatory strain (due to tidal breathing during spontaneous
respiration) and (in the event of mechanical ventilation) positive pressure. This exposure is especially problematic for the
cartilage-free bronchial tree. The effects of cyclic stretching (other than high-force stretching) have not been extensively
characterized. Hence, the objective of the present study was to investigate the functional and transcriptional response of
human bronchi to repetitive mechanical stress caused by low-frequency, low-force cyclic stretching.
Methods: After preparation and equilibration in an organ bath, human bronchial rings from 66 thoracic surgery patients
were stretched in 1-min cycles of elongation and relaxation over a 60-min period. For each segment, the maximal tension
corresponded to 80% of the reference contraction (the response to 3 mM acetylcholine). The impact of cyclic stretching
(relative to non-stretched controls) was examined by performing functional assessments (epithelium removal and
incubation with sodium channel agonists/antagonists or inhibitors of intracellular pathways), biochemical assays of the
organ bath fluid (for detecting the release of pro-inflammatory cytokines), and RT-PCR assays of RNA isolated from tissue
samples.
Results: The application of low-force cyclic stretching to human bronchial rings for 60 min resulted in an immediate,
significant increase in bronchial basal tone, relative to non-cyclic stretching (4.24 ± 0.16 g vs. 3.28 ± 0.12 g, respectively;
p < 0.001). This cyclic stimulus also increased the affinity for acetylcholine (−log EC50: 5.67 ± 0.07 vs. 5.32 ± 0.07,
respectively; p p < 0.001). Removal of airway epithelium and pretreatment with the Rho-kinase inhibitor Y27632 and
inward-rectifier K+ or L-type Ca2+ channel inhibitors significantly modified the basal tone response. Exposure to
L-NAME had opposing effects in all cases. Pro-inflammatory pathways were not involved in the response; cyclic
stretching up-regulated the early mRNA expression of MMP9 only, and was not associated with changes in organ
bath levels of pro-inflammatory mediators.
Conclusion: Low-frequency, low-force cyclic stretching of whole human bronchi induced a myogenic response rather
than activation of the pro-inflammatory signaling pathways mediated by mechanotransduction.
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Background
Airway tone (defined as the sustained contractile activa-
tion of airway smooth muscle (ASM)) and responsiveness
are the main functional characteristics of the bronchial
compartment of the lung; they provide an adaptive means
of adjusting air flow (all along the bronchial tree), the
work of breathing or alveolar pressure [1]. ASM respon-
siveness can be modulated by pharmacological agents,
inflammatory agents or external stimulation, such as the
cyclic stretching induced by mechanical ventilation [2]. In-
deed, the repetitive inflation-deflation caused by positive-
pressure ventilation may provoke a specific response by
the ASM, which is known to be adversely affected by
mechanical strain (especially high-amplitude strain) [3, 4].
Based on the cross-bridge model of contraction, mechan-
ical strain impairs force generation by disrupting acto-
myosin cross-bridge interactions [5]. There is also evidence
to suggest that strain modulates muscle stiffness and force
by inducting cytoskeletal remodeling - even at low levels of
strain (greater or equal to a lengthening of 3%) [5]. Length
adaptation may also contribute to airway hyperresponsive-
ness (AHR) in asthma [6]. Furthermore, ASM can adapt to
the changes in basal tone induced by contractile agonists in
a phenomenon known as force adaptation; this may stiffen
the ASM and prevent stretching of the ASM layer, thereby
limiting bronchoprotection [6].
Although the impact of cyclic stretching has been ex-
tensively investigated in isolated alveolar or ASM cells
[7–11], data on the putative effects on intact, fresh, hu-
man bronchi are scarce (especially for non-stimulated
airways) [12]. Some initial data have shown that stretch-
ing human bronchi for only 5 min (with a tension that
corresponded to an inflation pressure of more than
30 cm H2O) altered the crosstalk between airway cells
by (i) increasing epithelial leukotriene release via nitric
oxide synthase (NOS) activation and (ii) inducing a myo-
genic response that depends on the Rho-kinase- and
WNT-signaling pathways [13]. Moreover, studies in the
mouse have shown that mechanical ventilation can trig-
ger the release of pro-inflammatory cytokines by tracheal
tissues [14]. Recently, we developed and validated an in-
tegrated, ex vivo model for investigating the effects of
low-frequency, low-force cyclic stretching on human
bronchial tone and responsiveness [15]. The objective of
the present study was to investigate the functional and
transcriptional responses of intact human bronchi to the
repetitive mechanical stress caused by low-frequency,
low-force cyclic stretching.
Methods
Patients and human bronchus samples
Lung tissue was obtained from macroscopically healthy
parts of the lungs of 66 patients (44 males and 22
females; mean ± standard deviation age: 66 ± 10 years)
undergoing surgical resection for lung carcinoma. None
of the patients had a history of asthma, and all were
ex-smokers. The use of resected lung tissue for in vitro
experiments was approved by the local institutional re-
view board (Comité de Protection des Personnes Ile de
France VIII, Boulogne-Billancourt, France). All patients
provided their written informed consent to research use
of their samples. Tissue dissection was performed by
only one experienced operator (EN) in a strictly similar
manner, by starting at the main bronchus and then
following the bronchial tree to the tissue of interest, i.e.
the 4th or 5th level of bronchial division. Bronchial seg-
ments were excised from a site as far as possible from
the malignant lesion and then immersed in physiologic
saline solution (PSS) (NaCl: 119 mM, KCl: 4.7 mM,
CaCl2: 2.5 mM, KH2PO4: 1.2 mM, NaHCO3: 29 mM,
glucose: 11.7 mM) at 4 °C. After removal of adhering
lung parenchyma and connective tissue, eight similar
bronchial rings (length: 5 mm; inner diameter: 1–2 mm)
were prepared as previously described [15, 16].
Tissue preparation for organ bath studies
Bronchial rings were suspended horizontally on tissue
hooks in an organ bath containing 5 ml of PSS (gassed
with 95% O2, 5% CO2) and maintained at 37 °C (pH 7.40).
Each preparation was connected to a force displacement
transducer (it1, Emka Technologies, Paris, France). Iso-
metric tension was measured and processed with a com-
puterized system running IOX software (v2.4.2) and
analyzed with Datanalyst (v2.1.0) software (EMKA tech-
nologies, Paris, France). Bronchi were suspended with an
initial tension of 1.5 g [15] and equilibrated for 60 min.
During the equilibration period, the bath’s PPS was chan-
ged after 10, 20 and 30 min. At the end of this period,
bronchi were contracted with acetylcholine (3.10−3 M) to
determine the maximal tone (Emax) developed during
contraction in the absence of any treatment or pretreat-
ment. These experiments were run in parallel with appro-
priate controls (i.e. non-stretched rings or stretched but
non-pretreated rings). When required, the epithelium was
removed before suspension in the organ bath, as previ-
ously described [17].
Low-frequency, low-force cyclic stretching
The integrated model for cyclic stretching of isolated
human bronchi has already been described in detail and
validated [15]. Bronchi were stretched in 1-min cycles
over a 60-min period (Fig. 1). Briefly, the stretching cycle
consisted of three phases. The first 15-s phase corre-
sponded to an increase in the applied isometric force up
to two or three times the basal tone, i.e., an airway infla-
tion pressure of 30 cm H2O [14]; this limits the risk of
bronchial damage. This initial tensioning phase was di-
vided into two subphases: a steep increase over 10 s to
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just below the target value (but without exceeding 80%
of Emax), followed by a slower increase to the target
value over the last 5 s. These two subphases mimic the
increase in insufflated volume during volume-assisted
ventilation, and thus limited the risk of over-distension
and disruption of the bronchial tissue. The initial
tensioning phase was followed by a 15-s phase during
which the imposed tension returned to the baseline
value, and then a final 30-s phase with no imposed
changes in tension [15].
Functional assays
In order to investigate the putative signaling pathways in-
volved in the stretching-induced response of human bron-
chi and to characterize the bronchial ring’s responsiveness
profile, a cumulative concentration-response curve (CRC)
was first established for acetylcholine (ACh: 10 nM to
3 mM). After ACh washout and re-equilibration, samples
were pretreated for at least 15 min before the cyclic
stretching period. A second CRC for ACh was then estab-
lished (Fig. 1). The following pretreatment compounds
were added to the organ bath: (i) a cyclooxygenase (COX)
inhibitor (indomethacin, 1 μM); (ii) a leukotriene Cyst-LT1
receptor antagonist (MK476, 1 μM); (iii) a non-specific
NOS inhibitor at a high concentration (L-nitroarginine
methyl ester (L-NAME), 1 mM); (iv) a L-type calcium
channel blocker (nicardipine, 10 μM); (v) a natural blocker
of voltage-sensitive Na+ channels, with inhibition of action
potentials and nerve conduction (tetrodotoxin, 1 μM); (vi)
a nonspecific blocker of acid-sensing ion and stretch-
activated channels (gadolinium (Gd3+), 0.1 mM); (vii) an
inhibitor of the inward-rectifier K+ channel and large-
conductance, calcium-activated potassium channels
(tertiapin, 10 μM); (viii) a synthetic compound that acts as
an antagonist for the vanilloid transient receptor potential
1 (TRPV1) receptor and inhibits the cold-activated transi-
ent receptor potential melastatin 8 (TRPM8) channel
(capsazepine, 1 μM); (ix) a protein kinase C (PKC) blocker
(calphostin C, 0.1 μM); (x) an inhibitor of the 38-kDa
mitogen-activated protein kinase (MAPK) (SB203580,
0.1 μM); and (xi) a selective Rho-kinase (ROCK1 and
ROCK2) inhibitor (Y27632, 1 μM). The concentra-
tions of the various drugs were chosen on the basis
of the literature data.
Drugs
ACh, indomethacin, L-NAME, tetrodotoxin, Gd3+, nicar-
dipine, capsazepine, and calphostin C were purchased
from Sigma-Aldrich (St. Louis, MO, USA), tertiapin was
bought from Bachem (Voisin le Bretonneux, France),
Fig. 1 Effect of low-frequency, low-force cyclic stretching on bronchial basal tone and responsiveness to acetylcholine. The illustration is based
on a representative experiment. ACh, acetylcholine; CRC, concentration-response curves for ACh; (1), resting basal tone; (2), maximal bronchial
contraction in response to 3 mM ACh, before cyclic stretching; (3), pre-stretching bronchial tone; (4), bronchial tone at rest immediately after the
end of cyclic stretching; (5), post-stretching bronchial tone within 10 min following the cyclic stretching period; (6) maximal bronchial contraction
in response to 3 mM ACh after cyclic stretching. In the control group, bronchial tone did not change significantly between points 4 and 6 (data
not shown) (20)
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and SB-203580 was supplied by Calbiochem (San Diego,
CA, USA). MK476 came from Merck Sharp & Chibret
(Paris, France). Y27632 was purchased from Alexis Bio-
chemicals (San Diego, CA, USA). All drugs (other than
indomethacin, nicardipine and SB-203580) were dis-
solved in distilled water. Indomethacin was dissolved in
pure ethanol and then diluted in PSS. Nicardipine and
SB-203580 were dissolved in pure ethanol and DMSO
and then diluted in PSS. The final amounts of ethanol
and DMSO did not alter the responsiveness to ACh [18].
Analysis of the organ bath fluid
The organ bath levels of mediators involved in (i) the
regulation of bronchial basal tone (leukotriene E4 (LTE4)
and prostaglandin E2 (PGE2)), (ii) the interaction with
stretching-induced mechanotransduction (interleukin 8
(IL-8) and tumor necrosis factor-α (TNFα)) and (iii)
production of an anti-inflammatory effect (interleukin-10
(IL-10)) were measured immediately before and after
cyclic stretching by sampling 250 μl of organ bath fluid
from stretched bronchi and their paired, non-stretched
controls. Individual fluid samples were assayed using
specific ELISAs for stable excretory LTE4, PGE2, and
TNFα (Cayman Chemical Company, Ann Arbor, MI,
USA), IL-8 and IL-10 (R&D Systems Inc., Minneapolis,
MN, USA). The limit of detection was 25 pg/ml for LTE4,
36 pg/ml for PGE2, 7.5 pg/ml for IL-8, and 3.9 pg/ml for
IL-10 and TNFα. For each assay, all samples were
analyzed in a blind manner on the day of the experiment.
RNA isolation, and reverse transcription quantitative
polymerase chain reaction (RT-qPCR array analysis)
To isolate RNA and explore the transcriptional response
to cyclic stretching, paired bronchial rings (a control
ring and a stretched ring) were immediately immersed
in RNAlater reagent (Sigma, St. Louis, MO, USA) after
the experiment. The bronchi were frozen and stored at
− 80 °C until further use. (RT-qPCR) assays (using TaqMan
technology) were performed on bronchial segments that
had been crushed and homogenized in TRIzol® reagent
immediately after thawing and dissection, using a ball mill
TissueLyser LT (Qiagen, Courtaboeuf, France). Total RNAs
were extracted from the homogenates using TRIzol®
reagent and a method derived from that of Chomczynski
and Sacchi [19]. After crushing the preparation in an
RNAse-free environment, the amount of RNA extracted
was estimated spectrophotometrically at 260 nm (Biowave
DNA spectrophotometer; Biochrom, Cambridge, UK), and
the purity was assessed with a microfluidic electrophoresis
system (RNA Standard Sensitivity kits for Experion®,
BioRad, Marnes la Coquette, France). After a DNase treat-
ment step (DNase I, Life Technologies, Carlsbad, CA), 1 μg
of total RNA was reverse-transcribed (SuperScript® III
First-Strand SuperMix kit, Life Technologies). The resulting
cDNA was then used for RT-qPCR experiments in a
TaqMan® system (Life Technologies). 20 ng of cDNA was
amplified (Gene Expression Master Mix, Life Technologies)
in a StepOnePlus thermocycler (Life Technologies). The
amplification conditions were as follows: initial denatur-
ation at 95 °C for 10 min, followed by 40 cycles of anneal-
ing/extension (95 °C for 15 s, and then 60 °C for 1 min).
Fluorescence was measured at the end of each cycle, and
the threshold cycle (Ct) of the real-time qPCR was defined
as the point at which a fluorescence signal corresponding
to the amplification of a PCR product was detectable. The
reaction volume was 10 μl. The expression of transcripts of
the immediate-early genes of interest (WNT2, WNT3A,
WNT4, WNT5A, WNT7B, FZD7, MAPK1, MAPK3,
MAP3K14, MAPK9, MAPK14, CXCL8/IL8, COL4A1, ELN,
MMP9, LAMC1, MYC, and CACNA1S) [13] in the bronchi
was analyzed using a specific, predesigned TaqMan® Array
(Assay-on Demand, Life Technologies). In order to confirm
the extraction of intact cellular mRNA and standardize the
quantitative data, three reference genes (those coding for
hypoxanthine phosphoribosyltransferase (HPRT1),
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and
β-glucuronidase (GUSB)) were amplified simultaneously.
Data analysis
Data are presented as the mean ± standard error of the
mean, together with n (the number of experiments).
Bronchial tone and contractile responses are expressed
in units of tension (g). ACh efficacy (Emax) represents
the maximal contraction induced by 3 mM ACh, and
ΔEmax (g) represented the difference between Emax
(points 2 and 6, Fig. 1) and the basal tone recorded
before the CRC (points 1 and 5, Fig. 1). ACh potency
(−log EC50) represents the negative log of the ACh con-
centration that produced 50% of Emax. The quantitative
data obtained from RT-qPCR experiments correspond to
the relative expression (2−ΔCt), where ΔCt is the differ-
ence between the target gene Ct and the mean Ct of ref-
erence genes. The ELISA results are expressed as the
means of duplicate samples. Stretching-induced produc-
tion of LTE4, PGE2, IL-8, IL-10 or TNFα is expressed in
pg/mg of bronchial tissue, and corresponds to the differ-
ence in the amount (concentration × volume) of medi-
ator released into the organ bath immediately before
and after cyclic stretching. The results were analyzed
using Student’s t test for paired and normally distributed
data or using a Wilcoxon matched-pairs signed rank test
if the data were not normally distributed. The standard-
ized effect size |d| for the difference between the means
was calculated in order to determine whether the
observed effect of each pretreatment was small (|d| ≥ 0.20),
medium (|d| ≥ 0.50) or large (|d| ≥ 0.80), according to
Cohen’s conventions [20]. The 95% confidence interval (CI)
for d was calculated as a measure of the uncertainty with
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regard to the true effect of each pretreatment. A P
value < 0.05 was considered to be statistically
significant. Data analysis and statistical tests were
performed using Statistica’99 software, version 5.5,
StatSoft, Tulsa, OK, USA).
Results
Effect of cyclic stretching on bronchial basal tone and
responsiveness
In line with our previous published data [21], we ob-
served a direct effect of cyclic stretching on bronchial
tone at rest. Firstly, a spontaneous rise (points 3 to 4 in
Fig. 1) was observed immediately after the end of the
stretching (1.85 ± 0.06 g, versus 1.20 ± 0.07 g in paired
controls; P < 0.001, n = 66). An additional, post-stretching
increase in bronchial tone (points 4 to 5 in Fig. 1)
was also observed within 10 min of the end of the
cyclic stretching period (2.09 ± 0.07 g, versus 1.21 ±
0.07 g in paired controls, P < 0.001, n = 66). Cyclic
stretching was also associated with an increase in the
mean efficacy of ACh (Emax: 4.24 ± 0.16 g in
stretched rings, versus 3.28 ± 0.12 g in paired controls,
P < 0.001, n = 66) and the potency of ACh (−log EC50:
5.67 ± 0.07 g in stretched rings, versus 5.32 ± 0.07 g in
paired controls, P < 0.001, n = 66).
Effect of epithelium removal on the impact of cyclic
stretching
Epithelium removal was associated with a slight (but not
statistically significant) reduction in the immediate post--
stretching rise in bronchial tone (Table 1) and a signifi-
cantly lower late post-stretching rise (Table 2). Moreover,
epithelium removal tended to increase the bronchial re-
sponsiveness to ACh after cyclic stretching. However, the
small standardized size effect and the broad 95% CI indi-
cated a high degree of great uncertainty, and limited our
ability to draw conclusions about the true effect of the re-
moval procedure (Tables 3 and 4).
Effect of inhibiting the epithelial regulation of smooth
muscle contraction on the impact of cyclic stretching
Inhibition of COX with 1 μM indomethacin did not have
a significant impact on the stretching-induced increase
in bronchial tone and responsiveness to ACh (Tables 1,
2, 3 and 4, and Fig. 2). Likewise, blockade of leukotriene
cyst-LT1 receptors by MK476 did not have a significant
effect on the stretching-induced rises in bronchial tone
and responsiveness. In contrast, NOS inhibition by
1 mM L-NAME significantly increased the immediate
post-stretching rise in bronchial tone but did not have a
marked effect on the late post-stretching rise in bron-
chial tone or on responsiveness to ACh, as demonstrated
by the small standardized effect size and the correspond-
ing 95% CI.
Effect of drugs that decrease the intracellular Ca2+
concentration on the impact of cyclic stretching
Stretching-induced rises in bronchial tone and respon-
siveness were not significantly modified by pretreatment
with 10 μM nicardipine, 1 μM tetrodotoxin, 0.1 mM
Gd3+ or 1 μM capsazepine (Tables 1, 2, 3, and 4). In
contrast, blocking the inward-rectifier K+ channel and
the calcium-activated large conductance K+ channels by
applying 10 μM tertiapin significantly decreased the late
post-stretching increase in bronchial tone (Table 1).
Moreover, blockade of L-type calcium channels by
10 μM nicardipine strongly decreased the effect of cyclic
stretching on the potency of ACh, whereas blockade of
stretch-activated channels by Gd3+ accentuated the
effect of stretching (Tables 3 and 4).
Effect of inhibiting PKC, MAPK and Rho-kinase signaling
intracellular pathways on the impact of cyclic stretching
0.1 μM calphostin C or SB203580 had no effect on the
stretching-induced rises in bronchial tone and respon-
siveness to ACh (Tables 1, 2, 3, and 4). Inhibition of
Rho-kinases by 1 μM Y27632 significantly decreased the
immediate post-stretching increase bronchial tone at rest
but did not markedly modify the late post-stretching
increase or responsiveness to ACh (Fig. 2).
Transcript expression and ELISAs of organ-bath fluid
samples
Compared with paired, non-stretched controls, cyclic
stretching did not significantly modify the mRNA
expression of early genes involved in the WNT signaling
pathway (WNT2, WNT3A, WNT4, WNT5A, WNT7B
and FZD7), the MAPK signaling pathway (MAPK1 and
MAPK9), extracellular matrix modulation (ELN and
LAMC1) or actin filament modulation (COL4A1), stress
or inflammation (IL8/CXCL8, MAP3K14, and MAPK14)
or apoptosis (MYC) or the genes coding for type-L
calcium channels (CACNA1S), cholinergic receptors
(CHRNA7) or the β2−adrenergic receptor (ADRB2)
(Fig. 3). Only the mRNA expression of MMP9 was sig-
nificantly greater in stretched rings than in control rings.
Moreover, cyclic stretching of the same human bronchi
did not significantly change the levels of LTE4, PGE2,
IL-8, IL-10 and TNFα in the organ bath fluid, relative to
controls (Fig. 4).
Discussion
The present study extends our previous observations
whereby low-frequency, low-force cyclic stretching of
human bronchi was associated with elevated bronchial
tone at rest and greater responsiveness to ACh [15]. In
the experiments described above, drugs inhibiting pro-
inflammatory mediators or the pathways involved in
stretching-induced mechanotransduction had no effect
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on the magnitude of changes in bronchial tone and
responsiveness to ACh. Our results suggest that limiting
supraphysiologic stress during cyclic stretching may re-
duce the cascade of signaling events that transduce the
external tension from the extracellular matrix to the
actin cytoskeleton via the transmembrane integrins; in
turn, these signaling events result in the production of
contractile mediators, cytokines, growth factors and
specific stretch-activated channels, and are coupled with
early gene activation [13, 22–25]. This hypothesis is also
supported by the absence of an increase in the expres-
sion of early genes (other than MMP9) and the low
production of contractile epithelial mediators in re-
sponse to low-frequency, low-force cyclic stretching.
The stretching-induced rise in bronchial tone observed
in the present study was modulated by airway epithelium
Table 1 Effects of pretreatments on the bronchial tone at rest immediately after the end of cyclic stretch
Cyclic stretch effect on the basal tone during stretching period,
difference between control and stretch group
Effect of pretreatment Effect size pretreatment
n in absence of pretreatment (g) in presence of pretreatment (g) (g) |d| [95% CI]
Epithelium removal 13 0.76 ± 0.08a 0.53 ± 0.10a −0.23 ± 0.09 d −0.70 [−1.48 − 0.10]
Indomethacin (1 μM) 8 1.14 ± 0.2b 1.14 ± 0.18a 0.01 ± 0.10 0.00 [−1.01 − 1.01]
MK476 (1 μM) 7 1.22 ± 0.2b 0.89 ± 0.14a −0.33 ± 0.12d −0.68 [−1.70 − 0.44]
L-NAME (1 mM) 14 0.61 ± 0.15b 1.18 ± 0.15a 0.57 ± 0.14e 1.02 [0.20 − 1.77]
Nicardipine (10 μM) 10 0.65 ± 0.12a 1.03 ± 0.18a 0.38 ± 0.18 0.78 [−0.16 − 1.66]
Tetrodotoxin (1 μM) 7 1.07 ± 0.19b 1.29 ± 0.28b 0.22 ± 0.16 0.35 [−0.73 − 1.38]
Gadolinium (0.1 mM) 8 1.18 ± 0.20a 1.24 ± 0.15a 0.06 ± 0.18 0.12 [−0.87 − 1.10]
Tertiapine (10 μM) 9 0.51 ± 0.13b −0.74 ± 0.12a −1.25 ± 0.17f −3.32 [−4.50− −1.85]
Capsazepine (1 μM) 8 1.19 ± 0.14a 0.92 ± 0.20b −0.26 ± 0.23 −0.67 [−1.31− −0.01]
Calphostine C (0.1 μM) 9 1.10 ± 0.23a 1.12 ± 0.25b 0.02 ± 0.29 0.03 [−0.90 − 0.95]
SB203580 (0.1 μM) 10 1.11 ± 0.27b 0.84 ± 0.42 −0.27 ± 0.37 −0.24 [−1.11 − 0.65]
Y27632 (1 μM) 11 1.10 ± 0.25b −0.75 ± 0.30c −1.85 ± 0.50e −2.03 [−2.96– − 0.93]
The difference between pre-stretching basal tone and bronchial tone at rest immediately after the end of stretch (difference between the points 3 and 4, Fig. 1)
corresponded to the direct effect of cyclic stretch. Values are means ± standard error of the mean and standardized effect size |d| and its 95% confidence interval
[CI] for the difference between means. The observed effect of pretreatment is small (IdI ≥ 0.20), medium (IdI ≥ 0.50), or large (IdI ≥ 0.80) according to the Cohen’s
conventions [23]. The 95% CI for |d| consists of the uncertainty around the real effect of pretreatment. aP < 0.001, bP < 0.01, cP < 0.05 stretched vs. paired
non-stretched control bronchi. dP < 0.05, eP < 0.01, fP < 0.001 pretreatment vs. no pretreatment
Table 2 Effects of pretreatments on the post-stretch response in bronchial tone
Cyclic stretch effect on post-stretch response, difference between
control and stretch group
Effect of pretreatment Effect size pretreatment
n in absence of pretreatment (g) in presence of pretreatment (g) (g) |d| [95% CI]
Epithelium removal 13 0.24 ± 0.03a 0.15 ± 0.03a −0.09 ± 0.03d −3.00 [−4.01– − 1.80]
Indomethacin (1 μ M) 8 0.36 ± 0.07b 0.29 ± 0.07b −0.07 ± 0.11 −0.37 [−1.34–0.64]
MK476 (1 μM) 7 0.35 ± 0.08b 0.23 ± 0.06c −0.12 ± 0.10 −0.64 [−1.67–0.47]
L-NAME (1 mM) 14 0.29 ± 0.03a 0.21 ± 0.03a −0.08 ± 0.02d −0.73 [−1.47–0.06]
Nicardipine (10 μM) 10 0.17 ± 0.03a 0.12 ± 0.08a −0.05 ± 0.07 −0.27 [−1.13–0.63]
Tetrodotoxin (1 μM) 7 0.37 ± 0.08b 0.29 ± 0.06b −0.07 ± 0.10 −0.43 [−1.46–0.66]
Gadolinium (0.1 mM) 8 0.36 ± 0.07b 0.26 ± 0.03a −0.10 ± 0.08 −0.69 [−1.65 − 0.36]
Tertiapine (10 μM) 9 0.23 ± 0.06b 0.27 ± 0.04a 0.04 ± 0.08 0.26 [−0.68–1.18]
Capsazepine (1 μM) 8 0.29 ± 0.06b 0.37 ± 0.05a 0.08 ± 0.06 0.74 [−0.31–1.71]
Calphostine C (0.1 μM) 9 0.21 ± 0.03a 0.26 ± 0.02a 0.05 ± 0.05 0.65 [−0.32–1.57]
SB203580 (0.1 μM) 10 0.29 ± 0.05a 0.15 ± 0.19 −0.14 ± 0.22 −0.32 [−1.19–0.58]
Y27632 (1 μM) 11 0.28 ± 0.05a 0.33 ± 0.07b 0.05 ± 0.08 0.25 [−0.60–1.08]
The post-stretch response in bronchial tone corresponded to the spontaneous post-stretching increase within 10 min following the cyclic stretch period
(difference between the points 5 and 4, Fig. 1). Values are means ± standard error of the mean and standardized effect size |d| and its 95% confidence
interval [CI] for the difference between means. The observed effect of pretreatment is small (IdI ≥ 0.20), medium (IdI ≥ 0.50), or large (IdI ≥ 0.80) according
to the Cohen’s conventions [23]. The 95% CI for |d| consists of the uncertainty around the real effect of pretreatment. aP < 0.001, bP < 0.01, cP < 0.05
stretched vs. paired non-stretched control bronchi. dP < 0.05 pretreatment vs. no pretreatment
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removal, NOS inhibition, blockage of the inward-rectifier
K+ channel, and inhibition of Rho-kinases - suggesting
that cyclic stretching may impair the epithelial regulation
of ASM tone, alter ASM membrane depolarization, and
stimulate the Rho-kinase pathways. Moreover, the
stretching-induced increase in ACh potency involved the
intracellular Ca2+ concentration via the voltage-dependent
L-type Ca2+ channels but not via the stretch-activated
channels, since nicardipine (but not Gd3+) diminished the
effect of stretching. Overall, our results indicate that the
impact of low-frequency, low-force cyclic stretching
on the bronchial responsiveness to ACh might be
triggered by the Ca2+-dependent sensitization of ASM
contractile filaments.
Table 3 Effects of pretreatments on the stretch-induced change in maximal efficacy to acetylcholine
Cyclic stretch effect on ΔEmax (ACh) difference between control
and stretch group
Effect of pretreatment Effect size pretreatment
n in absence of pretreatment (g) in presence of pretreatment (g) (g) |d| [95% CI]
Epithelium removal 13 −0.01 ± 0.15 0.27 ± 0.14 0.27 ± 0.12a 0.54 [−0.26–1.29]
Indomethacin (1 μM) 8 0.12 ± 0.25 0.19 ± 0.11 0.07 ± 0.25 0.25 [−0.75–1.22]
MK476 (1 μM) 7 0.15 ± 0.29 0.51 ± 0.23 0.37 ± 0.28 0.53 [−0.57–1.55]
L-NAME (1 mM) 14 −0.01 ± 0.07 0.26 ± 0.14 0.25 ± 0.11a 0.66 [−0.12–1.40]
Nicardipine (10 μM) 10 0.25 ± 0.18 1.02 ± 0.44b 0.76 ± 0.43 0.73 [−0.21–1.60]
Tetrodotoxin (1 μM) 7 0.16 ± 0.25 −0.02 ± 0.12 −0.18 ± 0.30 −0.35 [−1.38–0.73]
Gadolinium (0.1 mM) 8 0.11 ± 0.22 0.39 ± 0.19 0.28 ± 0.28 0.49 [−0.53–1.45]
Tertiapine (10 μM) 9 −0.02 ± 0.08 0.25 ± 0.10b 0.27 ± 0.18 0.95 [−0.03–1.92]
Capsazepine (1 μM) 8 0.36 ± 0.26 0.29 ± 0.19 −0.07 ± 0.26 −0.11 [−1.08–0.88]
Calphostine C (0.1 μM) 9 0.00 ± 0.28 0.18 ± 0.22 0.18 ± 0.22 0.24 [−0.70–1.15]
SB203580 (0.1 μM) 10 −0.22 ± 0.21 −0.25 ± 0.16 −0.03 ± 0.25 −0.05 [−0.93–0.83]
Y27632 (1 μM) 11 −0.13 ± 0.22 0.21 ± 0.08b 0.33 ± 0.21 0.63 [−0.25–1.46]
ΔEmax represented the difference in maximal contraction between the pre-stretch (points 1 to 2) and the post-stretch (points 5 to 6) concentration-response
curves to ACh (Fig. 1). Values are means ± standard error of the mean and standardized effect size |d| and its 95% confidence interval [CI] for the dif-
ference between means. The observed effect of pretreatment is small (IdI ≥ 0.20), medium (IdI ≥ 0.50), or large (IdI ≥ 0.80) according to the Cohen’s
conventions [23]. The 95% CI for d consists of the uncertainty around the real effect of cyclic stretch. aP < 0.05 pretreatment vs. no pretreatment. bP < 0.05 stretched vs.
paired non-stretched control bronchi. ACh, acetylcholine
Table 4 Effects of pretreatments on the stretch-induced change in potency of acetylcholine
Cyclic stretch effect on Δ (−log EC50), difference between control
and stretch group
Effect of pretreatment Effect size pretreatment
n in absence of pretreatment
(log unit)
in presence of pretreatment
(log unit)
(log unit) |d| [95% CI]
Epithelium removal 13 0.48 ± 0.08a 0.50 ± 0.14b 0.02 ± 0.13 0.05 [−0.70–0.80]
Indomethacin (1 μM) 8 0.38 ± 0.07a 0.32 ± 0.13b −0.05 ± 0.12 −0.23 [−1.20–0.76]
MK476 (1 μM) 7 0.41 ± 0.07c 0.26 ± 0.23 −0.15 ± 0.24 −0.34 [−1.37–0.74]
L-NAME (1 mM) 14 0.30 ± 0.07a 0.44 ± 0.05a 0.14 ± 0.05 0.54 [−0.23–1.28]
Nicardipine (10 μM) 10 0.57 ± 0.10a 0.11 ± 0.12 −0.45 ± 0.17d −1.26 [−2.16– − 0.25]
Tetrodotoxin (1 μM) 7 0.25 ± 0.05c 0.38 ± 0.04a 0.13 ± 0.06 1.12 [−0.07–2.16]
Gadolinium (0.1 mM) 8 0.27 ± 0.05b 0.49 ± 0.08a 0.22 ± 0.08d 1.19 [0.07–2.18]
Tertiapine (10 μM) 9 0.40 ± 0.13b 0.41 ± 0.09c 0.03 ± 0.19 0.03 [−0.90–0.95]
Capsazepine (1 μM) 8 0.40 ± 0.11c 0.54 ± 0.12c 0.14 ± 0.15 0.41 [−0.60–1.38]
Calphostine C (0.1 μM) 9 0.26 ± 0.04a 0.24 ± 0.19 −0.01 ± 0.20 −0.04 [−0.80–0.88]
SB203580 (0.1 μM) 10 0.37 ± 0.07a 0.36 ± 0.10 −0.01 ± 0.13 −0.04 [−0.91–0.84]
Y27632 (1 μM) 11 0.37 ± 0.08a 0.37 ± 0.16b −0.01 ± 0.16 −0.12 [−0.95–0.72]
Δ (−log EC50) represented the change in potency between the pre-stretch and the post-stretch concentration-response curves to ACh (Fig. 1). Values are
means ± standard error of the mean and standardized effect size |d| and its 95% confidence interval [CI] for the difference between means. The
observed effect of pretreatment is small (IdI ≥ 0.20), medium (IdI≥ 0.50), or large (IdI ≥ 0.80) according to the Cohen’s conventions [23]. The 95% CI for d consists of the
uncertainty around the real effect of pretreatment. aP < 0.001, bP < 0.05, cP < 0.01 stretched vs. paired non-stretched control bronchi. dP < 0.05 pretreatment
vs. no pretreatment. ACh, acetylcholine
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In vivo, the intrinsic tone of the human bronchus is
modulated by both nervous stimulation and the balance
between the contractile mediators (leukotrienes and his-
tamine) and bronchodilatory mediators (PGE2 and nitric
oxide) secreted by the airway epithelium [26]. In previ-
ously published work on a model of a single, constant
stretch of human bronchial rings with a tension of 2.5
times the basal tone, the rise in bronchial tone following
stretching was associated with increased activity of the
epithelial Ca2 + −independent NOS-2 and the release of
LTE4 [13]. In the present study, none of the contractile
mediators of mechanotransduction was involved in the
stretching-induced rise in bronchial tone. The disparities





















































































Fig. 3 Effect of low-frequency, low-force cyclic stretching on the early mRNA-expression of genes involved in the WNT signaling pathway (WNT2,
WNT3A, WNT4, WNT5A, WNT7B and FZD7), the MAPK signaling pathway (MAPK1 and MAPK9), extracellular matrix modulation (ELN and LAMC1) or
actin filament modulation (COL4A1), stress or inflammation (IL8/CXCL8, MAP3K14, and MAPK14) or apoptosis (MYC) or the genes coding for type-L
calcium channels (CACNA1S), cholinergic receptors (CHRNA7) or the β2−adrenergic receptor (ADRB2) in 9 human bronchial rings. Values
were determined with RT-qPCR and are quoted as the relative expression level (2-ΔCt), where ΔCt is the difference between the target
gene’s Ct and the mean Ct for simultaneously amplified reference genes.
*P < 0.05 for stretched bronchi versus paired, non-stretched
control bronchi
Fig. 2 Significant effects of pretreatment in bronchial tone or responsiveness during and following 1 hour of low-force cyclic stretching. Three distinct
periods can be seen: during stretch (basal tone), 10 min after cyclic stretch (the post-stretch response) and the maximal tone after a dose–response to
acetylcholine (ACh). In all cases, epithelium removal and L-NAME pretreatment were significantly involved
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in our model of a single, constant stretch might be
explained by differences in the tension generated by the
experimental device or by differences in the stretching
duration. Therefore, the present findings suggest that
airway epithelial cells and pathways with short activation
times (such as cellular Ca2+ influx via membrane
depolarization and Rho-kinase activation) contribute to
the observed differences between a single stretch and
cyclic stretching, since epithelium removal and pretreat-
ment with tertiapin or Y27632 dampened the stretching-
induced rise in bronchial tone. Stretch-activated receptors
(which are located along the bronchial tree and may
increase airway tone through C-fiber nerve stimulation
when exposed to repetitive strain [27]) are unlikely to be
involved because pretreatment with tetrodotoxin (an
inhibitor of nerve conduction) did not change the
stretching-induced rise in bronchial tone. Similarly, the in-
volvement of stretch-activated channels or transient re-
ceptor potential ion channels (antagonized by Gd3+ and
capsazepine, respectively) seems unlikely. In agreement
with our previous results on a single, non-cyclic stretch,
our present data confirmed the involvement of Rho-
kinases in the rise in bronchial tone elicited by cyclic
stretching. However, Rho-kinases did not appear to be ac-
tivated by the early genes that interact with Wnt-signaling
pathways, as suggested by our previous experiments in a
model of supraphysiologic stretching [13]. These import-
ant observations suggest that limiting airway stretching to
the low tensions experienced under physiological condi-
tions might reduce the harmful effects of mechanical
ventilation on the bronchial compartment. Moreover, it
has been shown that the cessation of insufflation with tidal
volumes results in further bronchoconstriction within
1 min (regardless of the presence or absence of deep in-
spiration) [28], suggesting that further airway constriction
was solely due to the removal of tidal oscillations via two
separate effects (a reduction in the mean load on the ASM
and the disappearance of oscillatory load). Accordingly, in-
tegrity of the epithelium and the maintenance of a con-
stant level of force on the ASM appear to be essential for
preventing constriction. The low-force strain was enough
to increase the stiffness of the bronchial ring during our
dynamic and cyclic stretching, as suggested by Norris et
al.. The latter researchers described a biphasic ASM re-
sponse to an isovelocity stretch; the first phase concerned
the actomyosin interaction and the second phase was
dependent on the ASM’s level of activation [5]. The ab-
sence of a pre-inflammatory bronchial state is another
possible explanation for the absence of a rise in levels of
mediators. Previous studies have shown that a moderate
tidal volume during mechanical ventilation did not per se
cause extensive lung injury in normal lung but did in-
crease inflammatory responses in pre-injured lungs [29].
Although most studies have not observed an increase in
the levels of cytokines such as TNF-α and MIP-2 during
mechanical ventilation with moderate tidal volumes, a
more pronounced increase in these cytokines was ob-
served when mechanical ventilation was combined with
exposure to other harmful factors (such as lipopolysac-
charide) [30]. In accordance with these studies, our
present results show that moderate tidal stretch did not
induce the production of IL-8, IL-6 or TNF-α. The
Fig. 4 Effect of low-frequency, low-force cyclic stretching on the levels of leukotriene E4 (LTE4), prostaglandin E2 (PGE2), and interleukin-8 (IL-8), Tumor
necrosis factor-α (TNFα) and interleukin-10 (IL-10) in the organ bath (assessed with ELISAs) in 9 human bronchi. Cyclic stretching (filled bars) was not
associated with a significantly change in the production of mediators. Data are quoted as the mean ± SEM
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contractile apparatus in ASM might be the key effector in
the impact of cyclic stretching on bronchial tone. Indeed,
bronchial tone depends on the locked actin-myosin
bridges, which in turn are related to electromechanical
coupling in ASM [31]. The airway inflation-deflation
caused by breathing or deep inspiration exerts several dif-
ferent effects on the ASM’s contractile apparatus [32].
Cyclic stretching may alter the initial equilibrium by
enhancing polymerization of actin filaments via conform-
ational changes, intracytosolic calcium transfer and activa-
tion of the Rho-kinase pathway [33]. The post-stretching
increase in bronchial tone may result from ASM stiffness
or impaired bronchial relaxation. Indeed, we found that
the increase in bronchial tone was abolished by epithelium
removal and potentiated by the inhibition of NOS - sug-
gesting that stretching perturbs the epithelial regulation of
ASM [34]. A recent study of isolated ASM strips by Ansell
et al. demonstrated a significant difference in the maximal
contraction induced by electrical field stimulation after
sustained changes in length [35].
We found that cyclic stretching increased the potency
of ACh more than its efficacy. This phenomenon might
be mediated by Ca2+ sensitization or by the recruitment
of contractile units within ASM. However, we also found
that drugs that decrease the intracellular Ca2+ concen-
tration or inhibit the intracellular pathways involved in
Ca2+ sensitization (MAPK, PKC, and Rho-kinases) did
not prevent the hyperresponsiveness induced by cyclic
stretching; this finding indicates that the response to
stretching was myogenic and not related to Ca2+
sensitization. In this respect, it is known that force oscil-
lations cause rearrangements in the contractile appar-
atus, which can then generate a force that exceeds the
pre-stretching level [36–38]. The plasticity of ASM and
the latter’s structural adaptation to mechanical stress
may provide an alternative means of regulating bronchial
responsiveness [21]. Our results might also be explained
(at least in part) by the difference between the respective
effects of “stretch-compress” and “compress-stretch”
actions on ASM. In the case of a “stretch-compress”
action (as in the present study), the muscle tension rises
sharply at the start of the stimulus. This includes the re-
sponse of the bronchial tree embedded within the elastic
component of the bronchial structure [39].
It has been shown that cyclic stretching during mech-
anical ventilation with a high tidal volume induces the
activation of immediate-early genes (especially transcrip-
tion factors, stress proteins, and inflammatory media-
tors) in the alveolar compartment [40, 41]. Here, we
found that low-frequency, low-force cyclic stretching
only increased the expression of MMP9 mRNA in the
bronchial compartment. MMP9 is up-regulated by IL-8
and encodes an enzyme that degrades type IV and V col-
lagens (both of which are components of the airway
sub-epithelial basement membrane) and promotes the
relaxation of smooth muscle [42]. Lastly, the results of
our transcriptional analysis suggest that limiting airway
inflation may reduce the bronchial impact of mechanical
ventilation.
Our study had strengths and limitations. One notable
strength relates to the use of a tension corresponding to
each bronchial segment’s intrinsic properties. Stretching
the human bronchial rings with excessive tension would
doubtless have generated different results. A second
strength relates to the use of freshly human isolated
bronchi. This is of real importance because there are in-
terspecies differences in the modulation of airway tone
and responsiveness [23]. However, we cannot rule out
the possibility that bronchi from patients undergoing
thoracic surgery may have been stretched during the
surgical procedure. Due to ethical considerations, surgi-
cal specimens from healthy non-smokers are extremely
scarce and so specific analysis of this material could not
be performed. Moreover, further studies should focus
the effects of cyclic stretch at higher frequency. Another
study limitation relates to the fact that we did not meas-
ure the ring’s diameter during cyclic stretching; this
would have enabled us to model the induced strain. Fur-
thermore, the short time between stretching and mRNA
extraction may have restricted our investigation to very
early genes that were up- or down-regulated by cyclic
stretching. Lastly, as is the case with other isolated organ
models, our experiments were performed under non-
aerated conditions and in the absence of surfactant,
which could have promoted bronchial narrowing.
Conclusions
Taken as a whole, our results indicate that low-frequency,
low-force cyclic stretching of human bronchi increases
bronchial tone and responsiveness primarily via a myogenic
response mediated by adaptive changes in the physical state
of ASM. Although pro-inflammatory components (in either
the cytosol or the organ bath) did not seem to be involved
in this response to low-frequency, low-force cyclic stretch-
ing, interaction between epithelium and ASM emerged as a
major factor. Lastly, our findings in an experimental model
of cyclic stretching provide insights into the nature of
ventilator-induced lung damage.
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